Erythrocyte cell membrane (None in common usage; sometimes abbreviated as RBC membrane or RBCcm in scientific literature)
Target
None in common usage; sometimes abbreviated as RBC membrane or RBCcm in scientific literature
Molecular classification
Other (structure; not a receptor, enzyme, ion channel, or transporter), Cellular membrane, Composite of integral and peripheral membrane proteins, and lipids
01
Overview
The **erythrocyte cell membrane** is the specialized plasma membrane of red blood cells. It is a composite structure consisting of a lipid bilayer (made of cholesterol and phospholipids) and embedded proteins, providing elastic and mechanical stability, shape, and deformability to the cell. The membrane expresses numerous important blood group antigens (ABO, Rh, Kell, Duffy, etc.), which are crucial for transfusion compatibility. Its interaction with an underlying spectrin-based cytoskeleton confers unique flexibility, allowing erythrocytes to survive the mechanical stress of circulation and pass through narrow capillaries. Specific abnormalities or immune reactions directed against membrane-bound components can result in hemolytic disease or transfusion reactions.
Other names
Red blood cell membraneRBC membraneRBC cell membraneErythrocyte plasma membraneRBCcm
02
Mechanism of action
Not applicable at the structure level. Mechanisms pertain to specific proteins, e.g.:\n- Antibody-mediated destruction of cells presenting specific antigens (RhD, ABO)\n- Inhibition or modulation of ion transporters
03
Biological functions
Gas transport (indirectly, via anchoring hemoglobin and shape maintenance)Maintenance of erythrocyte shape and deformabilityExpression of blood group antigens (ABO, Rh, Kell, Duffy, etc.)Barrier functionCellular adhesionIon transport (via embedded transporters)
Hemolytic transfusion reactions if incompatible blood group antigens are presentDamage/mechanical fragility in genetic disorders (hereditary spherocytosis, elliptocytosis)Drug-induced hemolysis or oxidative damage
06
Interacting drugs
None directly target the "erythrocyte cell membrane" as a whole. Drugs and antibodies may interact with specific membrane proteins (e.g., anti-RhD immunoglobulin for Rh incompatibility, malaria-targeting therapies); treatments may affect red cell membrane indirectly (detergents, oxidizing agents in hemolytic anemia). For structured interaction, focus should be on specific antigens or proteins of the membrane.
07
Biomarkers
Blood group antigens (ABO, Rh, Kell, Duffy, etc.) for transfusion compatibility and disease susceptibilityMembrane protein mutations (Band 3, Spectrin, Ankyrin) in inherited anemias
Beyond the preview
Go deeper on Erythrocyte cell membrane (None in common usage; sometimes abbreviated as RBC membrane or RBCcm in scientific literature).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Erythrocyte cell membrane (None in common usage; sometimes abbreviated as RBC membrane or RBCcm in scientific literature).